Nerve injury increases brain-derived neurotrophic factor levels to suppress BK channel activity in primary sensory neurons

被引:60
|
作者
Cao, Xue-Hong
Chen, Shao-Rui
Li, Li
Pan, Hui-Lin [1 ,2 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Unit 110, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA
[2] Univ Texas Grad Sch Biomed Sci, Program Neurosci, Houston, TX USA
[3] Univ Texas Grad Sch Biomed Sci, Program Expt Therapeut, Houston, TX USA
基金
美国国家卫生研究院;
关键词
excitability; nerve injury; neurons; pain; plasticity; potassium channels; DORSAL-ROOT GANGLION; CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; CHRONIC CONSTRICTION INJURY; TYROSINE PROTEIN-KINASE; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; TACTILE ALLODYNIA; FIRING PROPERTIES; AFFERENT NEURONS;
D O I
10.1111/j.1471-4159.2012.07736.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
J. Neurochem. (2012) 121, 944953. Abstract Abnormal hyperexcitability of primary sensory neurons contributes to neuropathic pain development after nerve injury. Nerve injury profoundly reduces the expression of big conductance Ca2+ -activated K+ (BK) channels in the dorsal root ganglion (DRG). However, little is known about how nerve injury affects BK channel activity in DRG neurons. In this study, we determined the changes in BK channel activity in DRG neurons in a rat model of neuropathic pain and the contribution of brain-derived neurotrophic factor (BDNF) to reduced BK channel activity. The BK channel activity was present predominantly in small and medium DRG neurons, and ligation of L5 and L6 spinal nerves profoundly decreased the BK current density in these neurons. Blocking BK channels significantly increased neuronal excitability in sham control, but not in nerve-injured, rats. The BDNF concentration in the DRG was significantly greater in nerve-injured rats than in control rats. BDNF treatment largely reduced BK currents in DRG neurons in control rats, which was blocked by either anti-BDNF antibody or K252a, a Trk receptor inhibitor. Furthermore, either anti-BDNF antibody or K252a reversed reduction in BK currents in injured DRG neurons. BDNF treatment reduced the mRNA levels of BKa1 subunit in DRG neurons, and anti-BDNF antibody attenuated the reduction in the BKa1 mRNA level in injured DRG neurons. These findings suggest that nerve injury primarily diminishes the BK channel activity in small and medium DRG neurons. Increased BDNF levels contribute to reduced BK channel activity in DRG neurons through epigenetic and transcriptional mechanisms in neuropathic pain.
引用
收藏
页码:944 / 953
页数:10
相关论文
共 50 条
  • [11] Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons
    Mowla, SJ
    Pareek, S
    Farhadi, HF
    Petrecca, K
    Fawcett, JP
    Seidah, NG
    Morris, SJ
    Sossin, WS
    Murphy, RA
    JOURNAL OF NEUROSCIENCE, 1999, 19 (06): : 2069 - 2080
  • [12] Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ
    Balkowiec, A
    Katz, DM
    JOURNAL OF NEUROSCIENCE, 2000, 20 (19): : 7417 - 7423
  • [13] Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo
    Erickson, JT
    Brosenitsch, TA
    Katz, DM
    JOURNAL OF NEUROSCIENCE, 2001, 21 (02): : 581 - 589
  • [14] Siponimod increases brain-derived neurotrophic factor (BDNF) levels in the brain of EAE mice
    Bigaud, M.
    Afatsawo, C.
    Moebs, C.
    Rudin, S.
    Gonschorek, S.
    Schubart, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 465 - 465
  • [15] Brain-derived neurotrophic factor in primary headaches
    Marlene Fischer
    Georg Wille
    Stephanie Klien
    Hind Shanib
    Dagny Holle
    Charly Gaul
    Gregor Broessner
    The Journal of Headache and Pain, 2012, 13 : 469 - 475
  • [16] Chronic ketamine use increases serum levels of brain-derived neurotrophic factor
    Valerio Ricci
    Giovanni Martinotti
    Francesca Gelfo
    Federico Tonioni
    Carlo Caltagirone
    Pietro Bria
    Francesco Angelucci
    Psychopharmacology, 2011, 215 : 143 - 148
  • [17] Brain-derived neurotrophic factor in primary headaches
    Fischer, Marlene
    Wille, Georg
    Klien, Stephanie
    Shanib, Hind
    Holle, Dagny
    Gaul, Charly
    Broessner, Gregor
    JOURNAL OF HEADACHE AND PAIN, 2012, 13 (06): : 469 - 475
  • [18] Chronic ketamine use increases serum levels of brain-derived neurotrophic factor
    Ricci, Valerio
    Martinotti, Giovanni
    Gelfo, Francesca
    Tonioni, Federico
    Caltagirone, Carlo
    Bria, Pietro
    Angelucci, Francesco
    PSYCHOPHARMACOLOGY, 2011, 215 (01) : 143 - 148
  • [19] Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in rats
    Tripathi, Ashutosh
    Nasrallah, Henry A.
    Pillai, Anilkumar
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [20] Neuropeptide cycloprolylglycine increases the levels of brain-derived neurotrophic factor in neuronal cells
    Gudasheva, T. A.
    Koliasnikova, K. N.
    Antipova, T. A.
    Seredenin, S. B.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2016, 469 (01) : 273 - 276